Video
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
Chris Topoleski, director of federal regulatory affairs for ASHP, outlines the immediate impacts that achieving provider status would likely have on health-system pharmacists' practice.
This video was recorded at ASHP's Summer Meeting and Exposition in June 2015.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.